Conzone
Samuel Conzone, Castleton, NY US
Patent application number | Description | Published |
---|---|---|
20120148770 | FUSED QUARTZ TUBING FOR PHARMACEUTICAL PACKAGING - A high silica glass composition comprising about 82 to about 99.9999 wt. % SiO | 06-14-2012 |
20130095261 | FUSED QUARTZ TUBING FOR PHARMACEUTICAL PACKAGING - A high silica glass composition comprising about 92 to about 99.9999 wt. % SiO | 04-18-2013 |
20130338606 | SELF-LUBRICATING PHARMACEUTICAL SYRINGE STOPPERS - In one aspect, a self-lubricating component is provided for a pharmaceutical packaging assembly. The self-lubricating component comprises a polymer composition and an effective amount of a lubricating additive such as, for example, boron nitride. In another aspect, a pharmaceutical packaging assembly may be provided having a surface thereof coated with a lubricating composition comprising boron nitride. The pharmaceutical packaging composition may be, for example, a pre-filled syringe comprising a body (barrel) and a plunger assembly. | 12-19-2013 |
Samuel D. Conzone, Castleton, NY US
Patent application number | Description | Published |
---|---|---|
20110082430 | SELF-LUBRICATING PHARMACEUTICAL SYRINGE STOPPERS - In one aspect, a self-lubriating component is provided for a pharmaceutical packaging assembly. The self-lubricating component comprises a polymer composition and an effective amount of a lubricating additive such as, for example, boron nitride. In another aspect, a pharmaceutical packaging assembly may be provided having a surface thereof coated with a lubricating composition comprising boron nitride. The pharmaceutical packaging composition may be, for example, a pre-filled syringe comprising a body (barrel) and a plunger assembly. | 04-07-2011 |
20120065595 | SELF-LUBRICATING PHARMACEUTICAL SYRINGE STOPPERS - In one aspect, a self-lubricating component is provided for a pharmaceutical packaging assembly. The self-lubricating component comprises a polymer composition and an effective amount of a lubricating additive such as, for example, boron nitride. In another aspect, a pharmaceutical packaging assembly may be provided having a surface thereof coated with a lubricating composition comprising boron nitride. The pharmaceutical packaging composition may be, for example, a pre-filled syringe comprising a body (barrel) and a plunger assembly. | 03-15-2012 |
Samuel D. Conzone, Clarks Summit, PA US
Patent application number | Description | Published |
---|---|---|
20080213909 | PHARMACEUTICAL PACKAGING ASSAY - A pharmaceutical packaging assay for the determination of drug adsorption to the packaging surface(s) is described. The assay described utilizes fluorescent labeling of drugs in various formulations to determine the best packaging surface for drug stability as a function of adsorption. | 09-04-2008 |
Samuel David Conzone, Medina, OH US
Patent application number | Description | Published |
---|---|---|
20090000473 | GLASS-CERAMIC MEMBRANES - Disclosed are processes for preparing conductive glass-ceramic membranes. | 01-01-2009 |
20110177955 | MULTIPLEXED PROTEIN ADSORPTION ASSAY - A multiplexed assay method capable of measuring the interaction of one or more protein, polypeptide or peptide solutions with one or more substrate surfaces comprises contacting each of the wells of a multiwell substrate with the same or different protein solution, the surfaces of said wells being the same as that of said substrate or being substrate surface treated and/or coated to provide test surfaces, and determining the level of protein adsorption in each of said wells. | 07-21-2011 |
Samuel David Conzone, Clarks Summit, PA US
Patent application number | Description | Published |
---|---|---|
20120175558 | Nano-porous precursors for opto-ceramics via novel reactive dissolution - The invention relates to a process for preparing porous glass particles suitable for use as precursor materials for production of an opto-ceramic element. The process comprises: providing particles of a soluble glass composition comprising at least one soluble component, at least one component having low solubility in an aqueous solution, and at least one lasing dopant which also has a low solubility in the aqueous solution; and immersing the particles in an aqueous solution having low solubility for said at least one component and said at least one lasing dopant, to thereby dissolve substantially all of the soluble portions of the glass particles. | 07-12-2012 |